Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT06963112
PHASE1

Intraoperative Midazolam on Delirium Outcome of Elderly Patients

Sponsor: Chinese PLA General Hospital

View on ClinicalTrials.gov

Summary

This study was a multicenter, randomized, double-blind, placebo-controlled trial to treat elderly surgical patients with low-dose midazolam or placebo for anesthesia induction. The incidence of postoperative 7-day delirium was assessed and compared between two groups, to provide valuable reference for clinical practitioners in the use of midazolam in elderly surgical patients.

Official title: Impact of Intraoperative Midazolam on Delirium Outcome of Elderly Patients (I-IMODE): a Multicentre Randomised Controlled Trial

Key Details

Gender

All

Age Range

65 Years - 85 Years

Study Type

INTERVENTIONAL

Enrollment

612

Start Date

2025-04-01

Completion Date

2026-08-01

Last Updated

2025-09-25

Healthy Volunteers

No

Conditions

Interventions

DRUG

Midazolam

The intervention group patients were given 2mg midazolam injection (Jiangsu Enhua Pharmaceutical Co., Ltd.) during anesthesia induction

DRUG

Saline

The control group patients were given 2 mL physiological saline.

Locations (1)

Chinese PLA General Hospital

Beijing, China